StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3128
This month
51
This week
16
This year
337
Today
6
Yesterday
10
Publishing Date
2024 - 04 - 09
8
2024 - 03 - 28
9
2024 - 03 - 19
9
2024 - 03 - 13
8
2024 - 03 - 04
9
2024 - 02 - 29
8
2024 - 01 - 22
8
2024 - 01 - 16
8
2024 - 01 - 08
9
2023 - 12 - 21
12
2023 - 12 - 19
8
2023 - 12 - 12
10
2023 - 12 - 06
9
2023 - 11 - 28
9
2023 - 11 - 27
10
2023 - 10 - 26
8
2023 - 10 - 18
11
2023 - 10 - 16
10
2023 - 10 - 09
9
2023 - 10 - 04
9
2023 - 09 - 26
14
2023 - 09 - 25
9
2023 - 09 - 21
8
2023 - 09 - 20
8
2023 - 09 - 19
8
2023 - 09 - 07
10
2023 - 09 - 06
9
2023 - 08 - 15
9
2023 - 08 - 09
8
2023 - 06 - 26
9
2023 - 06 - 22
8
2023 - 06 - 15
11
2023 - 05 - 19
9
2023 - 04 - 25
10
2023 - 01 - 30
10
2023 - 01 - 26
8
2023 - 01 - 25
12
2023 - 01 - 24
8
2023 - 01 - 17
8
2022 - 12 - 01
8
2022 - 10 - 06
10
2022 - 09 - 16
7
2022 - 09 - 14
7
2022 - 09 - 06
7
2022 - 05 - 20
8
2021 - 09 - 17
7
2021 - 09 - 08
7
2021 - 06 - 25
10
2021 - 06 - 23
7
2021 - 06 - 21
7
2021 - 06 - 04
10
2021 - 06 - 03
8
2021 - 06 - 02
8
2021 - 06 - 01
7
2021 - 05 - 21
9
2021 - 05 - 06
7
2021 - 03 - 30
10
2021 - 03 - 22
9
2021 - 02 - 08
8
2020 - 12 - 15
8
Sector
Administrative and support and waste management and remediation services
2
Commercial services
31
Communications
48
Consumer durables
4
Consumer non-durables
17
Consumer services
10
Distribution services
18
Electronic technology
14
Energy minerals
2
Finance
103
Finance and insurance
8
Health care and social assistance
8
Health services
30
Health technology
2274
Industrial services
41
Information
5
Manufacturing
227
Mining, quarrying, and oil and gas extraction
5
N/a
112
Non-energy minerals
10
Process industries
107
Producer manufacturing
93
Professional, scientific, and technical services
69
Retail trade
7
Technology services
35
Transportation
10
Utilities
14
Wholesale trade
7
Tags
Alliances
98
Als
91
Application
381
Approval
371
Biotech
86
Biotech-bay
113
Biotech-beach
124
Cancer
622
Cell
87
Chmp
97
Clearance
139
Clinical-trials-phase-ii
204
Clinical-trials-phase-iii
140
Collaboration
98
Covid
177
Covid-19
139
Designation
429
Diabetes
94
Disease
531
Drug
573
Enroll
86
Europe
181
Events
96
Fast track designation
107
Fda
946
Fda-approvals
113
Food
87
Genetown
147
Global
213
Granted
154
Growth
158
Health
109
License
124
Market
358
Meeting
104
N/a
3128
New drug
97
Patent
147
Pharm-country
172
Pharma
91
Pharmaceuticals
248
Phase 1
179
Phase 2
249
Phase 2b
114
Phase 3
195
Positive
429
Potential
275
Preclinical
107
Report
153
Research
544
Results
241
Review
91
Study
321
Submission
87
Therapeutics
549
Therapy
350
Topline
108
Treatment
5293
Trial
859
Water
92
Entities
3m company
21
Abbott laboratories
47
Abbvie inc.
92
Accuray incorporated
17
Adamis pharmaceuticals corporation
11
Adial pharmaceuticals, inc
15
Albemarle corporation
11
Amgen inc.
34
Arcutis biotherapeutics, inc.
17
Astellas pharma inc
43
Astrazeneca plc
42
Bausch health companies inc.
28
Baxter international inc.
11
Biogen inc.
36
Bioxcel therapeutics, inc.
11
Boston scientific corporation
21
Brainsway ltd.
37
Bristol-myers squibb company
33
Calliditas therapeutics ab
12
Clearmind medicine inc.
13
Clene inc
11
Coherus biosciences, inc.
23
Compass pathways plc
16
Danaher corporation
12
Dow inc.
16
Dupont de nemours, inc.
13
Ecolab inc.
47
Eli lilly and company
129
Fortress biotech, inc.
18
Genmab a/s
13
Gilead sciences, inc.
14
Glaxosmithkline plc
93
Incyte corporation
41
Intellia therapeutics, inc.
25
Ionis pharmaceuticals, inc.
14
Jaguar health, inc.
15
Johnson & johnson
138
Karyopharm therapeutics inc.
27
Koninklijke philips n.v.
20
Medicinova, inc.
20
Medtronic plc
38
Novartis ag
134
Novo nordisk a/s
28
Orange
44
Pfizer, inc.
45
Pharvaris nv
13
Progyny, inc.
12
Regeneron pharmaceuticals, inc.
44
Sanofi
182
Scisparc ltd
12
Sorrento therapeutics, inc.
29
Takeda pharmaceutical company limited
30
Teleflex incorporated
19
Teva pharmaceutical industries ltd
67
Tg therapeutics, inc.
16
Tonix pharmaceuticals holding corp.
21
Ultragenyx pharmaceutical inc.
18
Verrica pharmaceuticals inc.
18
Viatris inc.
40
Xylem inc.
35
Symbols
ABBV
92
ABT
47
ADIL
15
ALPMF
43
ALPMY
43
AMGN
34
ARAY
17
ARQT
17
AZN
42
AZNCF
37
BHC
28
BIIB
36
BMY
33
BSX
21
BWAY
37
CALT
12
CHRS
23
CMND
13
CMPS
16
DD
13
DHR
12
DOW
16
ECL
47
FBIO
18
FNCTF
44
GILD
14
GLAXF
71
GMAB
13
GSK
92
INCY
41
IONS
14
JAGX
15
JNJ
138
KPTI
27
LLY
129
MDT
38
MMM
21
MNOV
20
NTLA
25
NVO
28
NVS
134
NVSEF
113
PFE
45
PGNY
12
PHG
20
PHVS
13
RARE
18
REGN
44
SNY
182
SNYNF
151
SPRC
12
SRNE
29
TAK
30
TEVJF
67
TFX
19
TGTX
16
TNXP
21
VRCA
18
VTRS
40
XYL
35
Exchanges
Amex
49
Nasdaq
2605
Nyse
886
Crawled Date
2024 - 04 - 09
8
2024 - 03 - 28
9
2024 - 03 - 19
10
2024 - 03 - 13
9
2024 - 03 - 04
9
2024 - 02 - 29
8
2024 - 01 - 22
8
2024 - 01 - 16
8
2024 - 01 - 08
9
2023 - 12 - 21
11
2023 - 12 - 19
8
2023 - 12 - 12
10
2023 - 12 - 06
9
2023 - 11 - 28
9
2023 - 11 - 27
11
2023 - 10 - 26
8
2023 - 10 - 18
11
2023 - 10 - 16
10
2023 - 10 - 09
9
2023 - 10 - 04
9
2023 - 09 - 26
14
2023 - 09 - 25
10
2023 - 09 - 21
8
2023 - 09 - 20
8
2023 - 09 - 19
8
2023 - 09 - 13
8
2023 - 09 - 07
10
2023 - 09 - 06
8
2023 - 08 - 15
9
2023 - 08 - 09
8
2023 - 06 - 26
9
2023 - 06 - 22
8
2023 - 06 - 15
11
2023 - 05 - 19
8
2023 - 04 - 25
8
2023 - 01 - 30
10
2023 - 01 - 25
13
2023 - 01 - 17
8
2022 - 12 - 01
8
2022 - 10 - 06
10
2022 - 09 - 14
7
2022 - 09 - 06
7
2022 - 05 - 20
8
2021 - 09 - 17
7
2021 - 09 - 08
7
2021 - 06 - 25
10
2021 - 06 - 23
7
2021 - 06 - 21
7
2021 - 06 - 04
10
2021 - 06 - 03
8
2021 - 06 - 02
8
2021 - 06 - 01
7
2021 - 05 - 21
9
2021 - 05 - 06
7
2021 - 03 - 30
9
2021 - 03 - 22
10
2021 - 03 - 02
7
2021 - 02 - 08
8
2020 - 12 - 21
8
2020 - 12 - 15
15
Crawled Time
00:00
91
00:01
2
00:12
2
00:20
19
01:00
85
02:00
37
03:00
26
04:00
19
04:20
16
05:00
26
06:00
60
06:03
2
07:00
52
08:00
41
08:20
4
09:00
44
10:00
46
10:16
6
11:00
237
11:03
3
12:00
454
12:01
9
12:03
16
12:07
3
12:11
3
12:15
41
12:20
74
12:30
85
13:00
309
13:02
3
13:03
14
13:05
4
13:14
3
13:15
24
13:20
64
13:30
50
14:00
142
14:01
11
14:02
3
14:03
6
14:04
3
14:15
12
14:20
21
14:30
21
15:00
71
15:01
3
15:15
6
15:20
18
15:30
19
16:00
71
16:20
31
17:00
67
18:00
62
19:00
73
20:00
106
20:20
17
21:00
122
22:00
104
22:01
3
23:00
92
Source
adialpharma.com
1
alteritytherapeutics.com
6
alzamend.com
1
apyxmedical.com
1
arcutis.com
2
brainsway.com
3
bridgebio.com
3
brightmindsbio.com
1
broadstone.com
1
canohealth.com
1
compasspathways.com
1
contravir.com
1
investor.alkermes.com
7
investor.aveooncology.com
4
investors.biomarin.com
5
investors.phiopharma.com
2
ir.ateapharma.com
5
ir.auriniapharma.com
6
ir.hoththerapeutics.com
3
ir.kalvista.com
6
ir.pulmatrix.com
3
ir.vtvtherapeutics.com
3
jaguarhealth.gcs-web.com
15
nanthealth.com
3
ocutx.gcs-web.com
3
renovorx.com
10
spacfeed.com
9
www.4dpharmaplc.com
9
www.akerotx.com
3
www.alnylam.com
4
www.ameresco.com
2
www.anaptysbio.com
4
www.anavex.com
2
www.beyondspringpharma.com
2
www.biolase.com
2
www.brainsway.com
27
www.clarivate.com
4
www.crinetics.com
3
www.enochianbio.com
2
www.fda.gov
6
www.globenewswire.com
1646
www.hepionpharma.com
2
www.igcinc.us
2
www.inovio.com
2
www.jupiterwellnessinc.com
2
www.kempharm.com
2
www.limoneira.com
3
www.marronebio.com
2
www.myriad.com
2
www.nanthealth.com
5
www.phiopharma.com
2
www.precisionbiosciences.com
2
www.prnewswire.com
1209
www.progyny.com
12
www.rubiustx.com
2
www.stagindustrial.com
2
www.sutrobio.com
3
www.uhsinc.com
2
www.vbivaccines.com
3
www.vynetherapeutics.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
tags :
N::A
save search
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published:
2024-04-17
(Crawled : 13:00)
- globenewswire.com
ABVC
|
$1.015
-9.38%
-10.34%
1.8M
|
Wholesale Trade
|
0.0%
|
O:
-1.79%
H:
0.0%
C:
0.0%
treatment
biopharma
royalties
global
for
agreement
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published:
2024-04-17
(Crawled : 12:00)
- prnewswire.com
NRBO
|
$3.56
4.71%
4.49%
11K
|
Health Technology
|
Email alert
Add to watchlist
da-1726
obesity
first
treatment
pharmaceuticals
for
trial
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
GENE
|
$3.12
-1.58%
-1.6%
13K
|
Health Technology
|
Email alert
Add to watchlist
GNTLF
|
$0.0007
1185.71%
2K
|
n/a
|
Email alert
Add to watchlist
precision
treatment
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
CMND
|
$1.185
-2.87%
-2.95%
1M
|
n/a
|
0.0%
|
O:
-0.82%
H:
0.0%
C:
0.0%
disorders
treatment
for
agreement
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published:
2024-04-17
(Crawled : 09:00)
- prnewswire.com
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-0.42%
|
O:
-0.04%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
0.0%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
global
growth
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
0.0%
|
O:
0.83%
H:
0.0%
C:
0.0%
kesimpta
sclerosis
novartis
show
benefits
Fracking Water Treatment Market size to record USD 1.20 billion growth from 2023-2027, Adoption of supercritical carbon in fracking is one of the key market trends, Technavio
Published:
2024-04-16
(Crawled : 23:00)
- prnewswire.com
AQUA
|
$49.88
0.0%
31M
|
Industrial Services
|
Email alert
Add to watchlist
XYL
|
$126.22
-1.39%
0.0%
1.4M
|
Producer Manufacturing
|
Email alert
Add to watchlist
water
one
treatment
key
growth
market
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
Published:
2024-04-16
(Crawled : 20:00)
- globenewswire.com
CLNN
|
$0.3375
8.87%
8.15%
9.7M
|
|
Email alert
Add to watchlist
au8
neurology
sclerosis
treatment
for
meeting
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-1.46%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$20.15
-0.89%
0.0%
790K
|
Health Technology
|
-1.64%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-1.36%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$16.41
1.3%
1.28%
350K
|
Health Technology
|
2.53%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
LXEO
|
$12.47
1.96%
1.92%
92K
|
|
2.56%
|
O:
5.32%
H:
0.0%
C:
-2.63%
lx2006
fda
candidate
granted
treatment
designation
for
therapeutics
therapy
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published:
2024-04-15
(Crawled : 21:00)
- globenewswire.com
ZVRA
|
$4.66
-2.31%
-2.36%
210K
|
n/a
|
-0.31%
|
O:
1.15%
H:
1.03%
C:
-1.45%
disease
treatment
for
meeting
therapeutics
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published:
2024-04-15
(Crawled : 20:00)
- prnewswire.com
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-2.5%
|
O:
-2.09%
H:
0.0%
C:
0.0%
opioid
million
treatment
for
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
RARE
|
$44.11
4.25%
4.08%
890K
|
Health Technology
|
-15.25%
|
O:
-10.79%
H:
0.0%
C:
-3.75%
gtx-102
positive
treatment
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
EGRX
|
$4.38
-6.61%
-7.08%
110K
|
Health Technology
|
-2.09%
|
O:
-8.14%
H:
19.55%
C:
18.18%
conference
treatment
pharmaceuticals
for
trial
response
Euro Tech Holdings Company Limited Reported An Exclusive Sales Distribution And OEM Partnership Agreement Covering Ballast Water Treatment Systems ("BWTS") Has Been Signed Between PACT And ERMA FIRST
Published:
2024-04-15
(Crawled : 11:00)
- prnewswire.com
CLWT
|
$1.58
-1.27%
3.2K
|
Electronic Technology
|
1.94%
|
O:
1.1%
H:
0.19%
C:
0.19%
sales
water
partnership
first
company
distribution
treatment
agreement
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
Published:
2024-04-15
(Crawled : 10:00)
- prnewswire.com
NCTY
|
$5.33
-4.82%
-5.07%
12K
|
Technology Services
|
-10.83%
|
O:
-4.94%
H:
0.0%
C:
0.0%
drug
precision
treatment
technology
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
Published:
2024-04-11
(Crawled : 14:00)
- globenewswire.com
OCUP
|
$1.745
0.29%
0.29%
92K
|
Health Technology
|
-6.45%
|
O:
-1.08%
H:
1.63%
C:
-2.72%
first
solution
light
treatment
for
study
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published:
2024-04-11
(Crawled : 13:00)
- globenewswire.com
CADL
|
$5.425
-7.9%
-8.57%
840K
|
|
15.49%
|
O:
25.49%
H:
23.75%
C:
13.75%
can-2409
fda
drug
cancer
pancreatic
treatment
designation
for
therapeutics
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT
Published:
2024-04-11
(Crawled : 12:00)
- apyxmedical.com
FNCTF
|
$11.0354
-20.84%
320
|
Communications
|
-1.12%
|
O:
-0.29%
H:
0.0%
C:
0.0%
APYX
|
$1.315
-5.4%
-5.7%
88K
|
Health Technology
|
-2.8%
|
O:
2.8%
H:
5.44%
C:
5.44%
renuvion
corporation
treatment
medical
apyx
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-1.85%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$33.44
0.0%
520K
|
Health Technology
|
-7.45%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
← Previous
1
2
3
4
5
6
7
8
9
…
156
157
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.